Christine M. Gould

发表

Designing specific protein kinase inhibitors: insights from computer simulations and comparative sequence/structure analysis.

Chung F Wong, Chung F. Wong, Christine M. Gould, 2002, Pharmacology & therapeutics.

The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C

A. Newton, J. Qin, B. Su, 2008, The EMBO journal.

Amplitude Control of Protein Kinase C by RINCK, a Novel E3 Ubiquitin Ligase*

A. Newton, Dan Chen, R. Hampton, 2007, Journal of Biological Chemistry.

Regulation of invadopodia by the tumor microenvironment

S. Courtneidge, Christine M. Gould, 2014, Cell adhesion & migration.

The life and death of protein kinase C.

A. Newton, Christine M. Gould, 2008, Current drug targets.

mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif

Susan S. Taylor, A. Newton, N. Kannan, 2021, Science Signaling.

The Chaperones Hsp90 and Cdc37 Mediate the Maturation and Stabilization of Protein Kinase C through a Conserved PXXP Motif in the C-terminal Tail*♦

Susan S. Taylor, A. Newton, N. Kannan, 2009, Journal of Biological Chemistry.

Active Site Inhibitors Protect Protein Kinase C from Dephosphorylation and Stabilize Its Mature Form*

A. Newton, M. Kunkel, A. Ziyar, 2011, The Journal of Biological Chemistry.

Interaction with AKAP79 modifies the cellular pharmacology of PKC.

A. Newton, L. Langeberg, John D. Scott, 2010, Molecular cell.

Active Site Inhibitors Protect Protein Kinase C from Dephosphorylation and Stabilize Its Mature Form*

A. Newton, M. Kunkel, Corina E. Antal, 2011, The Journal of Biological Chemistry.